 ?您的位置：對照品 > 標準品 > 歐洲藥典標準品 > |
|
|
|
| 產(chǎn)品基本信息 |
|
| 產(chǎn)品編號：A225100 |
| 產(chǎn)品名稱：Adaptaquin |
| 產(chǎn)品CAS：385786-48-1 |
| 規(guī)格含量：50mg |
| 產(chǎn)品價格：面議 |
| 聯(lián)系我們: |
 |
|
 |
|
|
| 產(chǎn)品詳細介紹 |
| 標準品編號: |
A225100 |
| 名稱: |
Adaptaquin |
| 別名: |
7-[(4-Chlorophenyl)[(3-hydroxy-2-pyridinyl)amino]methyl]-8-quinolinol |
| CAS號: |
385786-48-1 |
| 分子式: |
C??H??ClN?O? |
| 分子量: |
377.82 |
| 類別: |
Research Tools; Standards; Molecular Biology; Neurochemicals; Pharmaceutical/API Drug Impurities/Metabolites; |
| 應用: |
General Uses: Ischemic injury Research, Renal anemia, HIF Prolyl Hydroxylase Inhibitor, Antioxidant, Neuroprotective Description: Adaptaquin inhibits the HIF PHDs in brain in a dose dependent fashion and penetrates blood brain barrier (BBB). Exhibited functional recovery in intra-cerebral hemorrhage rat model; inhibits ATF4 gene. Potent HIF PHD inhibitor (hypoxia inducible factor), Selective PDH2 inhibitor. This compound is suitable for pyruvate dehydrogenase (PDH) related research. |
| 參考: |
|
|
|
|
|
|
